Radiopharm Theranostics (ASX:RAD)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Radiopharm Theranostics.
RELATED STOCKHEAD STORIES
Tony’s Takeaway: Replicating rewards
ASX Quarterly Health Wrap: Bioxyne revenue up 77%, Radiopharm lists on Nasdaq
Dr Boreham’s Crucible: Radiopharm hopes to turn up the sweet sound of success
Tony’s Takeaway: New year nuggets for biotech-hungry investors
ASX Lunch Wrap: ASX wobbles despite mining gains, and Goldman warns of correction
Health Check: Radiopharm dials up after gaining new major shareholder
Break it Down: Radiopharm Theranostics progresses along path to help heal HER-2 cancer
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
Health Check: Hearts aflutter as Echo IQ aces deal with major US teaching hospital
Tony’s Takeaway: Biotech buffet on the ASX
Health Check: Island Pharmaceuticals raises funds to put the mozz on dengue fever outbreak
Rise and Shine: Everything you need to know before the ASX opens
ASX Small Caps Lunch Wrap: Who’s been busted playing dress-ups in the US this week?
